Cargando…
Concurrent Systemic Chemoimmunotherapy and Sofosbuvir-Based Antiviral Treatment in a Hepatitis C Virus-Infected Patient With Diffuse Large B-Cell Lymphoma
Hepatitis C virus (HCV) infection is associated with the development of non-Hodgkin lymphomas. For aggressive lymphomas, such as diffuse large B-cell lymphoma (DLBCL), treatment of HCV infection is typically deferred in treatment-naive patients until after completion of lymphoma therapy [1, 2]. We r...
Autores principales: | Ewers, Evan C., Shah, Phalgoon A., Carmichael, Mark G., Ferguson, Tomas M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5170491/ https://www.ncbi.nlm.nih.gov/pubmed/28018926 http://dx.doi.org/10.1093/ofid/ofw223 |
Ejemplares similares
-
Fulminant Hepatic Failure as the Initial Presentation of Hodgkin Lymphoma in 4 Patients With Human Immunodeficiency Virus
por: Cook, Mary, et al.
Publicado: (2023) -
Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis
por: Ciardi, Maria R, et al.
Publicado: (2018) -
Primary Intramedullary Spinal Cord Lymphoma Presenting as a Cervical Ring–Enhancing Lesion in an AIDS Patient
por: Bini Viotti, Julia, et al.
Publicado: (2018) -
MRI and PET-CT Failed to Differentiate Between Hepatic Malignancy and Brucelloma
por: Schreiber, Peter W, et al.
Publicado: (2018) -
Comparative Antiviral Efficacy of Generic Sofosbuvir versus Brand Name Sofosbuvir with Ribavirin for the Treatment of Hepatitis C
por: Tang, L., et al.
Publicado: (2018)